How a new drug is born

Eur Heart J. 2021 Aug 21;42(32):3039-3041. doi: 10.1093/eurheartj/ehab076.

Authors

Andrea Caporali¹, Steven Fawell², Maurizio Scaltriti²

Affiliations

¹ University/BHF Centre for Cardiovascular Science, the University of Edinburgh, 47 Little France Crescent, Edinburgh, Scotland, EH16 4TJ, UK.
² Early Oncology, AstraZeneca, 35 Gatehouse Park, Waltham, MA 02451, USA.

PMID: 33718951
DOI: 10.1093/eurheartj/ehab076

No abstract available

MeSH terms

Antitubercular Agents* / therapeutic use
Humans
Pharmaceutical Preparations*

Substances

Antitubercular Agents
Pharmaceutical Preparations

Grants and funding

PG/16/58/32275/BHF_/British Heart Foundation/United Kingdom